Boost for EU materials technology sector:
This article was originally published in Clinica
Materials technology, a subject area that is critical to the future design of medical devices especially given growing environmental pressures, is to benefit from a new boost in the EU. The European Commission had agreed to support the chemical and biotechnology sector organisations, CEFIC and EuropaBio, in launching a Technology Platform on Sustainable Chemistry. This to establish a long-standing public-private partnership to increase investment on research and innovation and boost European competitiveness in this sector. Europe is a world leader in chemical products, holding 28% of the market, but its proportion of global trade has dropped by 4% over the last decade. As well as materials technology, the platform will address industrial biotechnology, and reaction and process design.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.